by Karen Riesenburger Poppel In 2012, Congress established certain processes in the Patent Office under which a third party could challenge the validity of issued patents. One of these processes, known as inter partes review (“IPR”), has been widely used. IPRs are typically filed by the Defendant/accused infringer in a concurrently pending federal patent infringement […]
Philadelphia, PA | October 2020 – RatnerPrestia’s James Matthew Gould will be speaking on “Recent Trends in ANDA Pharmaceutical Patent Litigation” at a virtual CLE meeting of the Philadelphia Intellectual Property Law Association on Wednesday, October 21, 2020 at 5:30 pm. The topic will focus on the recent Federal Circuit opinion in GlaxoSmithKline v. Teva […]
Philadelphia, PA | October 2020 – Robert A. Esposito of RatnerPrestia will co-present on the topic of “COVID Diagnosis Patent Eligibility With Respect to Recent Subject Matter Eligibility Cases and USPTO Guidance” on Thursday, October 15th at 6PM. Robert will be speaking on the subject matter eligibility of claims from recently published COVID focused patent […]
Philadelphia, PA | September 2020 – Jonathan H. Spadt, CEO & President of RatnerPrestia, will appear as a panelist on the 2020 Global Series Webcast, “SEP/FRAND Challenges: Unwired Planet: Implications and Strategies” on Friday, October 16, 2020 at 10:00 a.m. EDT. Hosted by The Federal Circuit Bar Association, the panel will explore the impacts of the decision, […]
Philadelphia, PA | September 2020 – Brett J. Rosen of RatnerPrestia will co-present along with Mark Rachlin of GlaxoSmithKline and Professor Amy Landers of Drexel University on the topic of the “Practice of IP during COVID” on Thursday, September 17th at 6:00 PM. One hour of Pennsylvania CLE will be offered for this virtual presentation […]
Philadelphia, PA | September 2020 – Andrew J. Koopman will be a co-speaker on the topic of “Intellectual Property Litigation – Strategies and Stories From Practice During the Pandemic” on Wednesday, September 16th at 5:30 PM EST. Hosted by the Philadelphia Intellectual Property Law Association, this CLE credited virtual meeting will present on the obstacles […]
Written by: Shayne D. Rasay & Jonathan H. Spadt Editor’s Note: This Summary addresses only 1 of 5 holdings in the case. For a thorough review of the complete decision, click here. The Court’s decision can be found here: https://www.supremecourt.uk/cases/uksc-2018-0214.html In Unwired Planet International Ltd. v. Huawei Technologies Co Ltd. [2020] UKSC 37, the UK […]
Written by: Shayne D. Rasay & Jonathan H. Spadt Editor’s Note: Given the complexity of the procedural history and number of issues on appeal, this paper cites directly to the numbered paragraphs of the Court’s decision, found here: https://www.supremecourt.uk/cases/uksc-2018-0214.html In Unwired Planet International Ltd. v. Huawei Technologies Co Ltd. [2020] UKSC 37, the UK Supreme […]
Philadelphia, PA | August 2020 – RatnerPrestia’s James Matthew Gould will be speaking on “Recent Developments Regarding License Agreements and Compulsory Licensing in the Life Sciences” on August 6, 2020, at the American Conference Institute’s upcoming 18th Advanced Summit on Life Sciences Patents. His topic will focus on compulsory licensing of patents around the world […]
Written by: Rex A. Donnelly On June 30, 2020, the U.S. Supreme Court issued an 8-1 opinion finding “Booking.com” is not generic for online hotel-reservation services, expressly declining to adopt a per se rule urged by the United States Patent and Trademark Office (USPTO) that would have essentially excluded registration of all “[generic term].com” marks. […]
